- Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
- Edwards Lifesciences to Acquire Innovalve
- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
More ▼
Key statistics
As of last trade Edwards Lifesciences Corp (EW:NYQ) traded at 87.75, -8.71% below its 52-week high of 96.12, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 86.68 |
---|---|
High | 88.50 |
Low | 86.50 |
Bid | 87.75 |
Offer | 87.76 |
Previous close | 86.50 |
Average volume | 3.47m |
---|---|
Shares outstanding | 602.60m |
Free float | 597.19m |
P/E (TTM) | 37.53 |
Market cap | 52.61bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 19:54 BST.
More ▼